These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

250 related articles for article (PubMed ID: 24616427)

  • 21. Influence of advanced age on Mycobacterium bovis BCG vaccination in guinea pigs aerogenically infected with Mycobacterium tuberculosis.
    Komine-Aizawa S; Yamazaki T; Yamazaki T; Hattori S; Miyamoto Y; Yamamoto N; Haga S; Sugitani M; Honda M; Hayakawa S; Yamamoto S
    Clin Vaccine Immunol; 2010 Oct; 17(10):1500-6. PubMed ID: 20685935
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Recombinant Mycobacterium smegmatis expressing an ESAT6-CFP10 fusion protein induces anti-mycobacterial immune responses and protects against Mycobacterium tuberculosis challenge in mice.
    Zhang H; Peng P; Miao S; Zhao Y; Mao F; Wang L; Bai Y; Xu Z; Wei S; Shi C
    Scand J Immunol; 2010 Oct; 72(4):349-57. PubMed ID: 20883320
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Potential of Mycobacterium tuberculosis resuscitation-promoting factors as antigens in novel tuberculosis sub-unit vaccines.
    Romano M; Aryan E; Korf H; Bruffaerts N; Franken CL; Ottenhoff TH; Huygen K
    Microbes Infect; 2012 Jan; 14(1):86-95. PubMed ID: 21920450
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The immunity and protective effects of antigen 85A and heat-shock protein X against progressive tuberculosis.
    Jeon BY; Kim SC; Eum SY; Cho SN
    Microbes Infect; 2011 Mar; 13(3):284-90. PubMed ID: 21093603
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Novel vaccines against M. tuberculosis].
    Okada M
    Kekkaku; 2006 Dec; 81(12):745-51. PubMed ID: 17240920
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Protective efficacy of a lipid antigen vaccine in a guinea pig model of tuberculosis.
    Larrouy-Maumus G; Layre E; Clark S; Prandi J; Rayner E; Lepore M; de Libero G; Williams A; Puzo G; Gilleron M
    Vaccine; 2017 Mar; 35(10):1395-1402. PubMed ID: 28190740
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Enhanced and durable protective immune responses induced by a cocktail of recombinant BCG strains expressing antigens of multistage of Mycobacterium tuberculosis.
    Liang J; Teng X; Yuan X; Zhang Y; Shi C; Yue T; Zhou L; Li J; Fan X
    Mol Immunol; 2015 Aug; 66(2):392-401. PubMed ID: 25974877
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The Impact of Genome Region of Difference 4 (RD4) on Mycobacterial Virulence and BCG Efficacy.
    Ru H; Liu X; Lin C; Yang J; Chen F; Sun R; Zhang L; Liu J
    Front Cell Infect Microbiol; 2017; 7():239. PubMed ID: 28642843
    [TBL] [Abstract][Full Text] [Related]  

  • 29. GI-19007, a Novel Saccharomyces cerevisiae-Based Therapeutic Vaccine against Tuberculosis.
    King TH; Shanley CA; Guo Z; Bellgrau D; Rodell T; Furney S; Henao-Tamayo M; Orme IM
    Clin Vaccine Immunol; 2017 Dec; 24(12):. PubMed ID: 29046306
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Intranasal Immunization with DnaK Protein Induces Protective Mucosal Immunity against Tuberculosis in CD4-Depleted Mice.
    Chuang YM; Pinn ML; Karakousis PC; Hung CF
    Front Cell Infect Microbiol; 2018; 8():31. PubMed ID: 29473022
    [No Abstract]   [Full Text] [Related]  

  • 31. Antigen 85 complex as a powerful Mycobacterium tuberculosis immunogene: Biology, immune-pathogenicity, applications in diagnosis, and vaccine design.
    Karbalaei Zadeh Babaki M; Soleimanpour S; Rezaee SA
    Microb Pathog; 2017 Nov; 112():20-29. PubMed ID: 28942172
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Recombinant bacille Calmette-Guerin coexpressing Ag85b, CFP10, and interleukin-12 elicits effective protection against Mycobacterium tuberculosis.
    Chen YY; Lin CW; Huang WF; Chang JR; Su IJ; Hsu CH; Cheng HY; Hsu SC; Dou HY
    J Microbiol Immunol Infect; 2017 Feb; 50(1):90-96. PubMed ID: 25732698
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Differential proteomics approach to identify putative protective antigens of Mycobacterium tuberculosis presented during early stages of macrophage infection and their evaluation as DNA vaccines.
    Sharma S; Rajmani RS; Kumar A; Bhaskar A; Singh A; Manivel V; Tyagi AK; Rao KV
    Indian J Exp Biol; 2015 Jul; 53(7):429-39. PubMed ID: 26245027
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Pathogenomic analyses of
    Orgeur M; Frigui W; Pawlik A; Clark S; Williams A; Ates LS; Ma L; Bouchier C; Parkhill J; Brodin P; Brosch R
    Microb Genom; 2021 Feb; 7(2):. PubMed ID: 33529148
    [No Abstract]   [Full Text] [Related]  

  • 35. A defined tuberculosis vaccine candidate boosts BCG and protects against multidrug-resistant Mycobacterium tuberculosis.
    Bertholet S; Ireton GC; Ordway DJ; Windish HP; Pine SO; Kahn M; Phan T; Orme IM; Vedvick TS; Baldwin SL; Coler RN; Reed SG
    Sci Transl Med; 2010 Oct; 2(53):53ra74. PubMed ID: 20944089
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Genome wide approaches discover novel Mycobacterium tuberculosis antigens as correlates of infection, disease, immunity and targets for vaccination.
    Coppola M; Ottenhoff TH
    Semin Immunol; 2018 Oct; 39():88-101. PubMed ID: 30327124
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Evaluation of a booster tuberculosis vaccine containing mycobacterial DNA-binding protein 1 and CpG oligodeoxynucleotide G9.1 using a Guinea pig model that elicits immunity to Bacillus Calmette-Guérin.
    Maeyama JI; Iho S; Suzuki F; Hayashi D; Yamamoto T; Yamazaki T; Goto Y; Ozeki Y; Matsumoto S; Yamamoto S
    Tuberculosis (Edinb); 2021 May; 128():102067. PubMed ID: 33752142
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Gene-based neonatal immune priming potentiates a mucosal adenoviral vaccine encoding mycobacterial Ag85B.
    Dai G; Rady HF; Huang W; Shellito JE; Mason C; Ramsay AJ
    Vaccine; 2016 Dec; 34(50):6267-6275. PubMed ID: 27823900
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Recombinant tuberculosis vaccine AEC/BC02 induces antigen-specific cellular responses in mice and protects guinea pigs in a model of latent infection.
    Lu JB; Chen BW; Wang GZ; Fu LL; Shen XB; Su C; Du WX; Yang L; Xu M
    J Microbiol Immunol Infect; 2015 Dec; 48(6):597-603. PubMed ID: 24863497
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Protective effect of a tuberculosis subunit vaccine based on a fusion of antigen 85B and ESAT-6 in the aerosol guinea pig model.
    Olsen AW; Williams A; Okkels LM; Hatch G; Andersen P
    Infect Immun; 2004 Oct; 72(10):6148-50. PubMed ID: 15385521
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.